Structural Characteristics of Heparin Binding to SARS-CoV-2 Spike Protein RBD of Omicron Sub-Lineages BA.2.12.1, BA.4 and BA.5

The now prevalent Omicron variant and its subvariants/sub-lineages have led to a significant increase in COVID-19 cases and raised serious concerns about increased risk of infectivity, immune evasion, and reinfection. Heparan sulfate (HS), located on the surface of host cells, plays an important rol...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Deling Shi, Changkai Bu, Peng He, Yuefan Song, Jonathan S. Dordick, Robert J. Linhardt, Lianli Chi, Fuming Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	SARS-CoV-2 Omicron spike protein RBD heparin pentosan polysulfate mucopolysaccharide polysulfate
Online Access:	https://www.mdpi.com/1999-4915/14/12/2696

Similar Items

Interactions of heparin with key glycoproteins of human respiratory syncytial virus
by: Deling Shi, et al.
Published: (2023-04-01)

Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate
by: Fuming Zhang, et al.
Published: (2022-02-01)

Synthesis of the Key Saccharide Fragments of the Glucuronic Acid-Containing Repeat Unit of Pentosan Polysulfate, a Heparin Sulfate Mimetic
by: Martin G. Banwell, et al.
Published: (2023-08-01)

Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor
by: Benjamin R. Lin, et al.
Published: (2025-06-01)

Experience of Using Pentosan Polysulfate SP 54 in Patients with Diabetic Foot Syndrome
by: I.V. Nosenko
Published: (2014-09-01)

Clinical curative effect of notoginseng powder and mucopolysaccharide polysulfate cream combined with microwave therapy in preventing the complications of arteriovenous fistula
by: YANG Ling, et al.
Published: (2015-01-01)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01)

Topical Application of OJI-204 Alleviates Skin Dryness, Dry Skin-Induced Itch, and Mechanical Alloknesis
by: Sumika Toyama, et al.
Published: (2025-02-01)

Xylan Prebiotics and the Gut Microbiome Promote Health and Wellbeing: Potential Novel Roles for Pentosan Polysulfate
by: Margaret M. Smith, et al.
Published: (2022-09-01)

Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow
by: H. M. Suranji Wijekoon, et al.
Published: (2018-05-01)

Effect of far-infrared therapy device on arteriovenous fistula maturation and lifespan in hemodialysis patients: a randomized controlled clinical trial
by: Jianqiang Huang, et al.
Published: (2023-09-01)

Colopathy associated with pentosan polysulfate use
by: Emily H. Jung, et al.
Published: (2025-07-01)

Preparation and characterization of fluorescent polysulfate based on fluorescein
by: LI Fu-chong1, LIU Wei2, CAO Wei2, LI Xu3, GUO Jun-hong1, CUI Jin-feng1, YANG Bao-ping1
Published: (2023-03-01)

An unusual case of rapid resolution of bilateral vitelliform deposits after discontinuation of pentosan polysulfate sodium
by: Fritz Gerald P. Kalaw, et al.
Published: (2023-12-01)

Anti-inflammatory actions of Pentosan polysulfate sodium in a mouse model of influenza virus A/PR8/34-induced pulmonary inflammation
by: Ravi Krishnan, et al.
Published: (2023-02-01)

Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use
by: Elena Flester, et al.
Published: (2024-12-01)

Performance, nutrient digestibility, and intestinal histomorphometry of broilers fed diet supplemented with chondroitin and glucosamine sulfates
by: Julyana Machado da Silva Martins, et al.
Published: (2020-08-01)

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
by: Carolina Torres, et al.
Published: (2023-01-01)

Multimodal imaging analysis and structure-function correlation in patients exposed to pentosan polysulfate sodium
by: Sandra Hoyek, et al.
Published: (2025-07-01)

Protective Effect of Far Infrared Therapy Using HITH-4 Type Apparatus and External Use of Hirudoid for Autogenous Arteriovenous Fistula in Diabetic Dialysis Patients
by: HU Chunyan, LI Yajing, GENG Tonghui, ZHANG Dongxue
Published: (2023-03-01)

<b>Structural features and inactivation of coagulation proteases of a sulfated polysaccharidic fraction from <i>Caulerpa cupressoides</i> var. <i>lycopodium</i> (Caulerpaceae, Chlorophyta)</b> - doi: 10.4025/actascitechnol.v35i4.16709
by: José Ariévilo Gurgel Rodrigues, et al.
Published: (2013-10-01)

Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data
by: Gary W. White
Published: (2025-09-01)

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
by: Andrés Carrazco-Montalvo, et al.
Published: (2022-05-01)

Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
by: Zhenhao Fang, et al.
Published: (2022-10-01)

Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
by: Jiali Wang, et al.
Published: (2024-04-01)

A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
by: Zhe Chen, et al.
Published: (2025-01-01)

Differences in Clinical Presentations of Omicron Infections with the Lineages BA.2 and BA.5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022
by: Katja Verena Goller, et al.
Published: (2022-09-01)

The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
by: Md. Rabiul Islam, et al.
Published: (2022-11-01)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2023-02-01)

Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5
by: Christian Setz, et al.
Published: (2023-07-01)

Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany
by: Katja Verena Goller, et al.
Published: (2024-03-01)

Outcome of Transplant Recipients Infected with Omicron BA.1 and BA.2: A Single-Center Retrospective Study in Saudi Arabia
by: Abeer N. Alshukairi, et al.
Published: (2023-01-01)

Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
by: Chloé Dimeglio, et al.
Published: (2022-09-01)

A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB
by: Yuan Ding, et al.
Published: (2023-03-01)

Viral load of SARS‐CoV‐2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
by: Yuna Takatsuki, et al.
Published: (2023-02-01)

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Research in context
by: Huiping Shuai, et al.
Published: (2023-09-01)

Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
by: Gabriel Diem, et al.
Published: (2023-06-01)

Impact of Omicron BA.5 infection on maternal and neonatal outcomes
by: Lu Li, et al.
Published: (2025-05-01)

First sequenced cases of Omicron BA.2 sublineage in Ecuador
by: D.A. Andrade-Molina, et al.
Published: (2023-09-01)

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
by: Aleksandr V. Kudriavtsev, et al.
Published: (2022-07-01)